Skip to main content
. 2022 Mar 9;17(3):e0264498. doi: 10.1371/journal.pone.0264498

Fig 5. Prevalence of Human papillomavirus (HPV) types targeted by current commercial HPV vaccines among women according to cervical disease status (Cervarix vaccine targets HPV–16/18; Gardasil–4 vaccine targets HPV–6/11/16/18 and Gardasil–9 vaccine targets HPV–6/11/16/18/31/33/45/52/58).

Fig 5